You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Anora Q3'24: Soft volumes
Av Rauli Juva
Anora lowered its guidance in October, and uncertainties remain regarding the end of the year as volumes have been under pressure. Anora’s CEO Jacek Pastuszka and CFO Stein Eriksen commented in an interview with analyst Rauli Juva.
Content:
00:00 Intro
00:13 Profit warning
03:02 Change of CEO
05:46 Key points of Q3
06:53 Gross margin of wine
07:46 Pricing
10:04 Guidance & outlook for Q4
11:25 Drivers of profitibality
12:44 Marketing
Herantis Pharma as an Investment | Life Science Night Dec. 2, 2024
Aiforia as an Investment | Life Science Night Dec. 2, 2024
Faron Pharmaceuticals as an Investment | Life Science Night Dec. 2, 2024
Life Science Companies as Investments | Life Science Night Dec. 2, 2024
Life Science Night | December 2, 2024
Titta på alla videor